June 19, 2026

Arteriovenous Malformations in Children: A Pediatric Neurosurgeons Perspective

This Neuroscience Grand Rounds session, led by Muhammad Osama, MD, provides a pediatric neurosurgeon’s perspective on arteriovenous malformations (AVMs) in children, rare but high-risk vascular lesions that can lead to seizures, neurological deficits, or life-threatening hemorrhage.

Phoenix Children's Medical Connection

June 19, 2026

Treatable Pediatric Neuromuscular Disorders

Through a case-based, evidence-driven approach, this Neuroscience Grand Rounds session highlights how clinicians can differentiate among neuromuscular conditions, localize disease processes and identify those disorders where timely treatment can significantly alter disease trajectory.

Phoenix Children's Medical Connection

June 19, 2026

Pediatric Bowhunter Syndrome: What Do We Know?

Bowhunter syndrome (BHS) is a rare but important cause of posterior circulation stroke in children, resulting from vertebral artery compression during head rotation.

Phoenix Children's Medical Connection

June 17, 2026

$1M Grant for Genetic Cataract Research

Lurie Children’s ophthalmologist receives $1 million National Institutes of Health grant to study pediatric cataract genetics

The Ophthalmologist

June 15, 2026

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

Conexiant

June 15, 2026

The Digital Migraine Revolution: How Headache Tracking and Digital Health Are Changing Pediatric Care

Pediatric migraine has historically been managed in fragments – symptoms recalled across months of episodic appointments. At Phoenix Children's, digital tools are reshaping care from episodic to continuous.

Phoenix Children's Medical Connection

June 11, 2026

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

Conexiant

May 25, 2026

Gene Therapy Reaches XLRS Milestone

Atsena Therapeutics reports positive interim data for XLRS gene therapy

The Ophthalmologist

May 20, 2026

Medical Oddities: Something Viral is Lurking in the Dust

Everyday things like yawns, tea, dust, and kimchi suddenly look medically important.

Conexiant

May 19, 2026

CT Use May Add to Future Cancer Burden

Researchers projected approximately 103,000 future cancers associated with computed tomography examinations performed in the US in 2023.

Conexiant